OMC
TBPH icon

Oasis Management Company’s Theravance Biopharma TBPH Stock Holding History

Oasis Management Company’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.92M Hold
583,490
– – 0.53% 18
2026
Q1 		$9.47M Sell
583,490
-143,671
-20% -$2.54M 0.55% 23
2025
Q4 		$13.6M Sell
727,161
-391,774
-35% -$6.5M 0.88% 13
2025
Q3 		$16.3M Hold
1,118,935
– – 1.57% 12
2025
Q2 		$12.3M Hold
1,118,935
– – 1.41% 13
2025
Q1 		$9.99M Buy
1,118,935
+3,170
+0.3% +$29.5K 1.9% 15
2024
Q4 		$10.5M Hold
1,115,765
– – 2.22% 11
2024
Q3 		$8.99M Sell
1,115,765
-42,200
-4% -$366K 1.94% 14
2024
Q2 		$9.82M Hold
1,157,965
– – 2.21% 10
2024
Q1 		$10.4M Buy
1,157,965
+151,107
+15% +$1.4M 3.07% 8
2023
Q4 		$11.3M Buy
1,006,858
+53,604
+6% +$539K 2.08% 11
2023
Q3 		$8.23M Buy
953,254
+306,981
+48% +$2.96M 0.36% 16
2023
Q2 		$6.69M Buy
646,273
+23,997
+4% +$265K 1.82% 18
2023
Q1 		$6.75M Buy
622,276
+325,316
+110% +$3.44M 1.08% 23
2022
Q4 		$3.33M Hold
296,960
– – 0.66% 25
2022
Q3 		$3.01M Buy
+296,960
New +$2.78M 0.51% 30

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Oasis Management Company's TBPH Position: Q2 2026 in Review

Oasis Management Company held its Theravance Biopharma (TBPH) position steady in Q2 2026 at 583,490 shares worth $9.92M. The position accounts for 0.53% of the portfolio, ranked #18.

Oasis Management Company first reported a position in TBPH in Q3 2022 and has held it in 16 quarters since. The position peaked at $16.3M in Q3 2025. 181 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Oasis Management Company held 583,490 shares of Theravance Biopharma worth $9.92M as of Q2 2026.
  • Oasis Management Company left its Theravance Biopharma share count unchanged in Q2 2026.
  • Theravance Biopharma made up 0.53% of Oasis Management Company's portfolio in Q2 2026, its #18 holding.
  • Oasis Management Company first reported a position in Theravance Biopharma in Q3 2022 and has held it in 16 quarters since.
  • Oasis Management Company's Theravance Biopharma position peaked at $16.3M in Q3 2025.
  • 181 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Oasis Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.